Exodus Point Capital Management, LP Bio Atla, Inc. Transaction History

Exodus Point Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 19, 2022	SELL	$2.13 - $5.38 $34,080 - $86,080	-16,000 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$4.38 - $18.78 $70,080 - $300,480	16,000 New	16,000 $80,000
Q1 2021 May 17, 2021	SELL	$32.41 - $70.91 $579,199 - $1.27 Million	-17,871 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$31.02 - $35.16 $554,358 - $628,344	17,871 New	17,871 $608,000

17.3M

500

33.5K

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $62.4M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.